The Abrams Center for Cosmetic Dentistry has taken a stand against oral cancer. We are now utilizing the OralID Fluorescence Technology in our office. We have joined with Forward Science the manufacturer of OralID, and became a member of the ID For Life Program to promote early detection and public awareness of oral cancer in the office. Dr Abrams and Dr Amann will be offering enhanced oral cancer screenings during scheduled appointments to new and current patients.
Oral Cancer is not a rare disease and unfortunately it is on the rise. This year, approximately 51,540 will be diagnosed with oral cancer in the United states alone. Due to late stage discovery one American dies every hour from oral cancer.
Dr Abrams and Dr Amann will be using an oral cancer screening device, OralID, in efforts to discover oral cancers in their earliest stages. Currently, up to 70% of oral cancers are found in late stages (stage III, IV), resulting in a 5-year survival rate of less than 50%. OralID has the ability to "highlight" these abnormalities in much earlier stages, before it is actually visible to your dental professional, in turn increasing the 5-year survival rate up to 80-90%.
Dr Abrams and Dr Amann has recognized the benefit of the Fluorescence Technology that OralID provides in efforts to discover oral cancer in its early stages and potentially save lives. Those interested in receiving an oral cancer screening at The Abrams Center for Cosmetic Dentistry, or to learn more about our advanced screening, contact our office at 610-993-8770 and ask about our OralID screenings.
On April 25, 2019 from 6-8 p.m. The Abrams Center will be holding an OPEN HOUSE for anyone to attend. We will be showing off the OralID device and what else our office and team have to deliver. Please stop by there will be light refreshments and a raffle for prizes.